Pharming Group N.V.
PHAR
$8.51
-$0.07-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | 191.55% | -192.34% | 78.65% | -61.94% | |
| Total Depreciation and Amortization | 3.70% | -109.27% | -6.40% | 48.59% | |
| Total Amortization of Deferred Charges | -3.62% | -- | 22.78% | -- | |
| Total Other Non-Cash Items | -19.04% | 84.15% | 2.97% | 306.59% | |
| Change in Net Operating Assets | -411.92% | -876.99% | -132.85% | -290.40% | |
| Cash from Operations | -19.40% | -37.42% | 121.15% | -72.04% | |
| Capital Expenditure | 57.24% | 72.24% | 0.33% | 57.02% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -168.04% | 155.24% | -3,734.04% | -132,100.00% | |
| Cash from Investing | -150.51% | 154.29% | -879.45% | -19,439.26% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -693.72% | -10,686.25% | 79.37% | -27.31% | |
| Issuance of Common Stock | 727.67% | -- | -78.13% | 944.74% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -157.12% | 101.04% | -2,402.13% | -18.08% | |
| Cash from Financing | -116.08% | -976.61% | -466.91% | 372.92% | |
| Foreign Exchange rate Adjustments | -795.90% | 181.58% | -96.75% | 92.17% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -180.67% | 94.04% | -61.97% | -3,894.69% | |